Skip to main content
Equibles

BOOTHBAY FUND MANAGEMENT, LLC

Position in JSPR — Jasper Therapeutics, Inc.

CIK 1549230 NEW YORK, NY
Back to JSPR Full portfolio

Position in JSPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$510,489 QoQ
Shares Held
357,447
-62.0% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in JSPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $666,641,771 across 159 Biotechnology names. JSPR ranks #152 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 465,787 $87,232,589
2 ABVX
Abivax S.A.
 563,367 $75,074,286
3 EXEL
Exelixis, Inc.
 804,095 $43,750,808
4 PCVX
Vaxcyte, Inc.
 534,163 $31,050,895
5 COGT
Cogent Biosciences, Inc.
 692,825 $26,812,327
6 CGEM
Cullinan Therapeutics, Inc.
 1,082,611 $19,714,346
7 TNGX
Tango Therapeutics, Inc.
 500,497 $15,645,536
8 AVTX
Avalo Therapeutics, Inc.
 702,051 $12,973,902

All Filings in JSPR

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $510,489 582,751
2025-12-31 $1,452,935 793,954
2025-09-30 $1,053,487 442,642
2024-12-31 $296,177 13,853
2024-09-30 $230,159 12,236
2024-06-30 $529,454 23,324
2024-03-31 $684,792 23,324
2023-09-30 $163,211 233,159
2023-06-30 $319,427 233,159
2023-03-31 $422,466 233,407